Implementing a multidisciplinary approach to reducing inhaler emissions

The propellants in metered-dose inhalers (MDIs) are potent greenhouse gases. Despite their small size, MDIs account for a substantial proportion of health system GHG emissions. MDIs are an attractive target for emissions reduction efforts because prescribing is under health systems’ control, and there are alternative, lower-emission prescribing pathways, some of which offer the co-benefit of improved patient outcomes.

Learn how diverse stakeholders can work together to develop and implement practical strategies for reducing MDI emissions through quantification and analysis of MDI prescribing patterns and climate impact; clinician and patient education; development of clinical decision support tools integrated into the electronic record; and evaluation of health system and health plan policies related to MDIs.

Session objectives:

• Understand the importance of a multidisciplinary team for reducing inhaler emissions.
• Learn specific strategies to reduce emissions from MDIs.
• Understand the complexities and barriers to inhaler emissions reduction within clinical care.
• Hear about opportunities for stakeholder engagement in reducing inhaler-based GHG emissions.